Imago BioSciences, Inc. – NASDAQ:IMGO

Imago BioSciences stock price today

$36.01
+36.01

Imago BioSciences stock price monthly change

-100.00%
month

Imago BioSciences stock price quarterly change

-100.00%
quarter

Imago BioSciences stock price yearly change

-100.00%
year

Imago BioSciences key metrics

Market Cap
N/A
Enterprise value
N/A
P/E
-19.72
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
7.04
PEG ratio
0.14
EPS
-1.85
Revenue
N/A
EBITDA
-62.12M
Income
-62.62M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Imago BioSciences stock price history

Imago BioSciences stock forecast

Imago BioSciences financial statements

Imago BioSciences, Inc. (NASDAQ:IMGO): Profit margin
Dec 2021 0 -14.72M
Mar 2022 0 -16.45M
Jun 2022 0 -13.88M
Sep 2022 0 -17.54M
Imago BioSciences, Inc. (NASDAQ:IMGO): Earnings per share (EPS)
2022-05-12 -0.42 -0.49
2022-08-12 -0.5 -0.41
2022-11-09 -0.44 -0.5
Imago BioSciences, Inc. (NASDAQ:IMGO): Debt to assets
Dec 2021 224786000 10.09M 4.49%
Mar 2022 212446000 12.93M 6.09%
Jun 2022 196111000 8.77M 4.47%
Sep 2022 186457000 13.83M 7.42%
Imago BioSciences, Inc. (NASDAQ:IMGO): Cash Flow
Dec 2021 -13.29M -61.08M 390K
Mar 2022 -11.52M 8.09M 454K
Jun 2022 -15.76M 30.26M 17K
Sep 2022 -11.71M -3.28M -475K

Imago BioSciences alternative data

Imago BioSciences, Inc. (NASDAQ:IMGO): Employee count
Aug 2023 41
Sep 2023 41
Oct 2023 41
Nov 2023 41
Dec 2023 41
Jan 2024 41
Feb 2024 41
Mar 2024 41
Apr 2024 41
May 2024 41
Jun 2024 41
Jul 2024 41

Imago BioSciences other data

Imago BioSciences, Inc. (NASDAQ:IMGO): Insider trades (number of shares)
Period Buy Sel
Jan 2022 0 28000
Feb 2022 0 58500
Jul 2022 0 1750
Aug 2022 0 25603
Nov 2022 0 1303
Dec 2022 0 940889
Transaction Date Insider Security Shares Price per share Total value Source
Option
CHIANG HSIANGYI officer: Senior Vice President ..
Stock Option (Right to Buy) 19,941 $4.2 $83,752
Option
CHIANG HSIANGYI officer: Senior Vice President ..
Common Stock 19,941 $4.2 $83,752
Option
RIENHOFF HUGH JR director, officer.. Stock Option (Right to Buy) 7,415 $2.52 $18,686
Option
RIENHOFF HUGH JR director, officer.. Common Stock 7,415 $2.52 $18,686
Option
RIENHOFF HUGH JR director, officer.. Common Stock 4,761 $2.52 $11,998
Option
TAPPER AMY E. officer: Stock Option (Right to Buy) 1,379 $22.76 $31,386
Option
TAPPER AMY E. officer: Stock Option (Right to Buy) 12,400 $4.2 $52,080
Option
TAPPER AMY E. officer: Stock Option (Right to buy) 7,482 $2.52 $18,855
Option
TAPPER AMY E. officer: Common Stock 1,379 $22.76 $31,386
Option
TAPPER AMY E. officer: Common Stock 12,400 $4.2 $52,080
  • What's the price of Imago BioSciences stock today?

    One share of Imago BioSciences stock can currently be purchased for approximately $36.01.

  • When is Imago BioSciences's next earnings date?

    Unfortunately, Imago BioSciences's (IMGO) next earnings date is currently unknown.

  • Does Imago BioSciences pay dividends?

    No, Imago BioSciences does not pay dividends.

  • What is Imago BioSciences's stock symbol?

    Imago BioSciences, Inc. is traded on the NASDAQ under the ticker symbol "IMGO".

  • What is Imago BioSciences's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Imago BioSciences?

    Shares of Imago BioSciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Imago BioSciences's key executives?

    Imago BioSciences's management team includes the following people:

    • Dr. Hugh Young Rienhoff Jr. Chief Executive Officer & Director(age: 72, pay: $530,920)
    • Dr. Amy E. Tapper Ph.D. Senior Vice President of Chemistry, Manufacturing & Controls and Non-Clinical Devel.(age: 54, pay: $352,080)
    • Ms. Jennifer Peppe Senior Vice President of Clinical Operations(age: 54, pay: $346,980)
  • How many employees does Imago BioSciences have?

    As Jul 2024, Imago BioSciences employs 41 workers.

  • When Imago BioSciences went public?

    Imago BioSciences, Inc. is publicly traded company for more then 4 years since IPO on 16 Jul 2021.

  • What is Imago BioSciences's official website?

    The official website for Imago BioSciences is imagobio.com.

  • Where are Imago BioSciences's headquarters?

    Imago BioSciences is headquartered at 329 Oyster Point Boulevard, South San Francisco, CA.

  • How can i contact Imago BioSciences?

    Imago BioSciences's mailing address is 329 Oyster Point Boulevard, South San Francisco, CA and company can be reached via phone at +41 55295055.

Imago BioSciences company profile:

Imago BioSciences, Inc.

imagobio.com
Exchange:

NASDAQ

Full time employees:

41

Industry:

Biotechnology

Sector:

Healthcare

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

329 Oyster Point Boulevard
South San Francisco, CA 94080

CIK: 0001623715
ISIN: US45250K1079
CUSIP: 45250K107